Scarica l'app Stockscreener
28.32
0.81%
-0.23
Dopo l'orario di chiusura:
28.30
-0.02
-0.07%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PFE Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Pfizer Inc Borsa (PFE) Ultime notizie
Raab & Moskowitz Asset Management LLC Sells 39,910 Shares of Pfizer Inc. $PFE - MarketBeat
SteelPeak Wealth LLC Grows Position in Pfizer Inc. $PFE - MarketBeat
Poland, Romania Ordered to Honor Vaccine Deal with Pfizer - Insider Monkey
Pfizer Inc. (PFE) latest press releases and corporate news - Yahoo Finance Singapore
How Pfizer’s Lyme Vaccine Trial Results Could Shape Pipeline Renewal for Pfizer (PFE) Investors - simplywall.st
Only one U.S. university ranks in the world’s top 10 in STEM. Pfizer’s CEO is calling for change - Yahoo Finance
Pfizer Loses Bid to Dismiss Disability Bias Lawsuit - National Today
Pfizer Fails to Escape Warehouse Worker’s Disability Bias Suit - Bloomberg Law News
Ever Wonder How Medicines Get Their Names? - Pfizer
38,600 Shares in Pfizer Inc. $PFE Acquired by Genesis Financial Group LLC - MarketBeat
Pfizer Inc. $PFE Stock Position Reduced by First Pacific Financial - MarketBeat
Aberdeen Group plc Sells 664,801 Shares of Pfizer Inc. $PFE - MarketBeat
Declaration of shares and voting rights of Valneva SE – March 2026 - GlobeNewswire Inc.
Pfizer Site Closure Puts Cost Focus And R&D Productivity In Spotlight - Yahoo Finance
Pfizer RSV vaccine offered to 3M more in England (PFE:NYSE) - Seeking Alpha
Pfizer Site Closure Tests Cost Cuts And R&D Footprint Against Valuation - simplywall.st
Pfizer price soarsForecast today02-04-2026 - economies.com
Pfizer, BioNTech Halt Large US COVID-19 Vaccine Trial Over Slow Enrollment - BioSpace
Pfizer’s RSV Shot to Be Offered to 3 Million More in England - Bloomberg.com
Pfizer Inc. $PFE Shares Purchased by Penn Davis Mcfarland Inc. - MarketBeat
Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 - GlobeNewswire
Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 & 2035United Therapeutics Corporation, APEIRON Biologics, Pfizer, Bayer, and Amgen Dominate - Yahoo Finance
PFE Stock Quote Price and Forecast - CNN
GSK plc (ADR) Stock: ViiV Healthcare Ownership Restructured as Pfizer Exits, Strengthening GSK's HIV - AD HOC NEWS
Pacer S&P 500 Quality FCF High Dividend ETF's Pfizer Inc(PFE) Holding History - GuruFocus
Pfizer and BioNTech halt U.S. COVID-19 vaccine study after recruitment struggles - The Japan Times
Why Pfizer (PFE) Outpaced the Stock Market Today - Yahoo Finance
Leerink maintains Pfizer stock rating after vaccine ruling - Investing.com
What's Going On With Pfizer Stock Wednesday?BioNTech (NASDAQ:BNTX), Pfizer (NYSE:PFE) - Benzinga
Pfizer, BioNTech halt US trial of COVID-19 vaccine over low enrollment - Daily Sabah
Pfizer, BioNTech end U.S. COVID vaccine trial over low participation: Reuters - Seeking Alpha
Pfizer (PFE) Wins EU Court Case on Vaccine Contracts - GuruFocus
Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID shots - marketscreener.com
Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles - marketscreener.com
Belgian court orders Poland, Romania to accept $2.2B of Pfizer COVID shots - Seeking Alpha
Pfizer Inc. - Britannica
Pfizer and partner BioNTech say they will stop U.S. COVID-19 vaccine study in healthy adults ages 50 to 64 due to slow enrollment - marketscreener.com
Pfizer Wins €1.9 Billion Covid Vaccine Case With Poland, Romania - Bloomberg.com
PFE Stock Trades Above 200 & 50-Day SMA for 3 Months: How to Play - TradingView
Bearish on Pfizer (PFE) as Big Dividend Fails to Mask the Growth Problem - Yahoo Finance
Pfizer (PFE) Competes in Prostate Cancer Treatment Landscape - GuruFocus
Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines - Reuters
Will Pfizer’s Lyme disease gamble pay off or set the space back? - Pharma Voice
Belgium court orders Romania to take delivery of 600 mln euros worth of Pfizer Covid vaccines - MarketScreener
Pfizer Pulls Back From South San Francisco - tradingview.com
Belgium court orders Poland to take delivery of 1.3 bln euros worth of Pfizer COVID vaccines - marketscreener.com
March Social Media Round-Up—2025 Annual Review, World’s Most Ethical Companies, and More - Pfizer
GSK, Pfizer and Shionogi finalize changes to ViiV Healthcare ownership - Investing.com
Pfizer (PFE) Valuation Check As Phase 3 Lyme Vaccine And Prostate Cancer Results Draw Focus - simplywall.st
Pfizer exits ViiV as GSK (NYSE: GSK) keeps 78.3% stake, Shionogi grows - Stock Titan
Meyer Handelman Co. Sells 50,802 Shares of Pfizer Inc. $PFE - MarketBeat
Shrier Wealth Management LLC Purchases New Stake in Pfizer Inc. $PFE - MarketBeat
Advanced Renal Cell Carcinoma Treatment Market to Grow by $3.1 Billion During 2026-2030: Global Industry Assessment Featuring Pfizer, Merck & Co., Bristol-Myers Squibb, AstraZeneca, Novartis and More - Yahoo Finance
Pfizer Inc. $PFE Shares Bought by Capital Advisors Inc. OK - MarketBeat
Shionogi completes purchase of Pfizer stake in GSK's ViiV Healthcare - London South East
Pfizer Inc. (PFE.SW) Stock Forum & Discussion - Yahoo! Finance Canada
Pfizer, BioNTech to pause COVID vaccine study due to low enrollment - BioPharma Dive
Pfizer's Strategic Pivot: Cost-Cuts Fuel New Growth Bets - AD HOC NEWS
Moderna, Pfizer Want Bayer's COVID-Shot Patent Suits Tossed - Law360
Pfizer (NYSE:PFE) Trading Up 1.1%What's Next? - MarketBeat
Pfizer to exit South San Francisco space — and with it, the Bay Area - The Business Journals
Pfizer Inc. stock rises Tuesday, still underperforms market - MarketWatch
Pfizer Stock Edges Higher as Oncology Wins and Pipeline Bets Fuel Optimism Amid Flat 2026 Outlook - inkl
Pfizer, Bain Must Litigate Cerevel Investors’ AbbVie Deal Suit - Bloomberg Law News
Pfizer is said to close South San Francisco research site - Seeking Alpha
Pfizer Inc. (NYSE:PFE) Tracks Healthcare Allocation In S&P 500 fund - Kalkine Media
Moderna, Pfizer Press to Toss Bayer’s Covid-Shot Patent Suits - Bloomberg Law News
Exclusive: Pfizer to shutter South S.F. research site, end Bay Area presence - San Francisco Chronicle
Is Pfizer Stock a Buy? Shares Hit Fresh High as Bulls and Bears Clash Over Valuation - TechStock²
Pfizer Inc Stock (PFE) Moved Up by 3.06% on Mar 31: Facts Behind the Movement - TradingKey
1.37%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):